ArticleEuropean radiology2024

CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors.

Jiazheng Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.